Mark W Viner MD

Summary

• Supplemental CV Cannabis Medicine
  
  Civic Participation:
  
  Local
  •    Reno Medical Doctor participant for Panel Workshop entitled -An Educational Look at Marijuana in Nevada -at the Potentialist Workshop in Reno on 4/20/2016
  
  State
  •    The State of Utah Department of Health and Human Services’ Cannabis Research and Review Board (CRRB) monthly meetings public comments. These meetings were held virtually only, and was open to the public, 2021-2023
  
  •    The State of Utah- Medical Cannabis Qualified Medical Provider QMP-20-0000001366; 5/2023-5/2025
  
  Federal
  •    FDA-2019-N-1482-0001 Food and Drug Administration Health and Safety Risks; Scientific Data and Information about Products Containing Cannabis or Cannabis Derived Compounds Public Hearing Presentation on May 31, 2019
  
  
  •    DEA-2024-0059-0001, Drug Enforcement Agency, Schedules of Controlled Substances: Rescheduling of Marijuana, Comment on FR Doc # 2024-1137; Comment ID DEA-2024-0059-31210; July 16, 2024
  
  Academic
  •    Medical Journal Reviewer, Frontiers in Oncology, Manuscript Reviewed: Meta-analysis of medical cannabis outcomes and associations with cancer. Front Oncol. 2025 Apr 15; 15:1490621. doi: 10.3389/fonc.2025.1490621. PMID: 40303989; PMCID: PMC12037605.
  
  •    Journal of the American Medical Association (JAMA) Commentary on: Gilman JM. Association of Cannabis Legalization with Prevalence of Schizophrenia—Challenges of Attributing Biological Causality to Policy Change. JAMA Netw Open. 2025;8(2): e2457876. doi:10.1001/jamanetworkopen.2024.57876
  
  •    Journal of the American Medical Association Psychiatry (JAMA Psychiatry) Commentary on: Chung T, Steinberg ML, Bridgeman MB. Recommendation for Cannabis Use Disorder Diagnosis in a Context of Cannabis for Therapeutic Purposes. JAMA Psychiatry. 2023;80(5):409–410. doi:10.1001/jamapsychiatry.2023.0053
  
  
  Psychiatric Times; Multivideo series in https://www.psychiatrictimes.com/topics/cannabis;
  February 2025:
  
  
  1.    https://www.psychiatrictimes.com/view/exploring-the-crossroa
Regulations.gov
FDA Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments in May 2019